Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Francesco Giunta

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
The Oncologist|August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO NetworkPasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Medical Oncology (Northwood, London, England)|February 11, 2021
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotypeDavide Ciardiello, Bernadette Blauensteiner, Nunzia Matrone, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
ESMO Open|April 3, 2020
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello, et al.
Cancers|October 11, 2019
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution ExperiencePietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta, et al.
The New England Journal of Medicine|October 22, 2025
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder CancerThomas Powles, Ariel G Kann, Daniel Castellano, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The Oncologist|August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO NetworkPasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Medical Oncology (Northwood, London, England)|February 11, 2021
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotypeDavide Ciardiello, Bernadette Blauensteiner, Nunzia Matrone, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
ESMO Open|April 3, 2020
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello, et al.
Cancers|October 11, 2019
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution ExperiencePietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta, et al.
The New England Journal of Medicine|October 22, 2025
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder CancerThomas Powles, Ariel G Kann, Daniel Castellano, et al.
Pageof 6